×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SKYE – skye bioscience, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SKYE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/18
07:00 am
skye
Skye Bioscience to Participate in Upcoming December Healthcare Investment Conferences
Medium
Report
Skye Bioscience to Participate in Upcoming December Healthcare Investment Conferences
11/14
07:09 am
skye
Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor [Yahoo! Finance]
Medium
Report
Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor [Yahoo! Finance]
11/14
07:00 am
skye
Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor
Medium
Report
Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor
11/7
04:01 pm
skye
Skye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights
Medium
Report
Skye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights
11/4
07:00 am
skye
Skye Bioscience Demonstrates Prominent Role of Peripheral CB1 Inhibition and Achieves Significant Weight Loss with Novel CB1-inhibiting Antibody, Nimacimab, in Preclinical Model
Medium
Report
Skye Bioscience Demonstrates Prominent Role of Peripheral CB1 Inhibition and Achieves Significant Weight Loss with Novel CB1-inhibiting Antibody, Nimacimab, in Preclinical Model
11/1
07:00 am
skye
Skye Bioscience to Announce Third Quarter 2024 Results
Medium
Report
Skye Bioscience to Announce Third Quarter 2024 Results
10/29
07:00 am
skye
Skye Bioscience Names Independent Director Paul Grayson as Chairman of the Board
Low
Report
Skye Bioscience Names Independent Director Paul Grayson as Chairman of the Board
10/21
07:00 am
skye
Skye Bioscience to Participate in Upcoming November Healthcare Investment Conferences
Medium
Report
Skye Bioscience to Participate in Upcoming November Healthcare Investment Conferences
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/20
08:24 am
skye
Form 4 Skye Bioscience, Inc. For: Nov 15 Filed by: Diep Tuan Tu
Medium
Report
Form 4 Skye Bioscience, Inc. For: Nov 15 Filed by: Diep Tuan Tu
11/19
09:57 pm
skye
Form 4 Skye Bioscience, Inc. For: Nov 15 Filed by: ARSENAULT KAITLYN
Medium
Report
Form 4 Skye Bioscience, Inc. For: Nov 15 Filed by: ARSENAULT KAITLYN
11/19
09:21 pm
skye
Form 4 Skye Bioscience, Inc. For: Nov 15 Filed by: DHILLON PUNIT
Medium
Report
Form 4 Skye Bioscience, Inc. For: Nov 15 Filed by: DHILLON PUNIT
11/19
09:15 pm
skye
Form 4 Skye Bioscience, Inc. For: Nov 15 Filed by: Grayson Paul A.
Medium
Report
Form 4 Skye Bioscience, Inc. For: Nov 15 Filed by: Grayson Paul A.
11/15
05:31 pm
skye
Form 144 Skye Bioscience, Inc. Filed by: ARSENAULT KAITLYN
Medium
Report
Form 144 Skye Bioscience, Inc. Filed by: ARSENAULT KAITLYN
11/15
05:29 pm
skye
Form 144 Skye Bioscience, Inc. Filed by: DHILLON PUNIT
Medium
Report
Form 144 Skye Bioscience, Inc. Filed by: DHILLON PUNIT
11/15
05:26 pm
skye
Form 144 Skye Bioscience, Inc. Filed by: Diep Tuan Tu
Medium
Report
Form 144 Skye Bioscience, Inc. Filed by: Diep Tuan Tu
11/15
05:22 pm
skye
Form 144 Skye Bioscience, Inc. Filed by: Grayson Paul A.
Medium
Report
Form 144 Skye Bioscience, Inc. Filed by: Grayson Paul A.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: